United States · FDA National Drug Code directory

Triamterene and Hydrochlorothiazide

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 55289-488_419ac74d-7d69-dca8-e063-6294a90a447d
Product NDC: 55289-488
Form: TABLET
Composition / generic term: Triamterene and Hydrochlorothiazide
Labeler: PD-Rx Pharmaceuticals, Inc.
Marketing category: ANDA
Marketing start / end (source format): 19930923
Source listing expiry: 20261231

Source-listed ingredients

TRIAMTERENE — 75 mg/1
HYDROCHLOROTHIAZIDE — 50 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

100 TABLET in 1 BOTTLE, PLASTIC (55289-488-01) · 55289-488-01
15 TABLET in 1 BOTTLE, PLASTIC (55289-488-15) · 55289-488-15
30 TABLET in 1 BOTTLE, PLASTIC (55289-488-30) · 55289-488-30
90 TABLET in 1 BOTTLE, PLASTIC (55289-488-90) · 55289-488-90

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →